Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.

Menopause can cause changes in your oral health. A dentist explains what changes you can expect from menopause and what you ...

If you've suddenly noticed that your gums feel tender or they bleed a little when you brush your teeth, a shift in hormones might be to blame—especially if you're a woman. As women go through life, a ...